Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Biological effects after prenatal irradiation (embryo and fetus): ICRP Publication 90 Approved by the Commission in October 2002
2003
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Viridans Group Streptococcal Infections Among Children With Cancer and the Importance of Emerging Antibiotic Resistance
2006
Milk-derived exosomes for oral delivery of paclitaxel
2017 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
2005
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Cremophor EL
2001 Standout
Block copolymer micelles: preparation, characterization and application in drug delivery
2005 Standout
Nanosuspensions in drug delivery
2004
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Risks of leukaemia and solid tumours in individuals with Down's syndrome
2000
Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome
2012
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Polymeric micelles for drug delivery
2005
Reflex control of immunity
2009 Standout
Transient Leukemia (Transient Myeloproliferative Disorder, Transient Abnormal Myelopoiesis) of Down Syndrome
2006
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study
1998
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
2003
Microtubules as a target for anticancer drugs
2004 Standout
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Natural compounds for cancer treatment and prevention
2009 Standout
Down's syndrome
2003 Standout
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
Moderate and severe traumatic brain injury in adults
2008 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Health Supervision for Children With Down Syndrome
2011 Standout
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation
2007
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Down syndrome
2020 Standout
Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics
2015
Delivering nanomedicine to solid tumors
2010 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Donor HLA-specific Abs: to BMT or not to BMT?
2015
Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function
2004
Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
2018
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Down Syndrome
2020 Standout
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
2017
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities
2017
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Zygomycetes in Human Disease
2000 Standout
Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application
2016 Standout
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Desensitization for solid organ and hematopoietic stem cell transplantation
2014
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
2006
Transient myeloproliferative disorder in children with D own syndrome: clarity to this enigmatic disorder
2012
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Down syndrome and leukemia: insights into leukemogenesis and translational targets.
2015
Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein
2003
Pharmacological Effects of Formulation Vehicles
2003
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial
2017
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Development Strategies and Prospects of Nano-based Smart Pesticide Formulation
2017 Standout
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
Guidelines for Treatment of Candidiasis
2004 Standout
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome
2003
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Clinical Practice Guideline: Otitis Media with Effusion (Update)
2016 Standout
Works of John Doyle being referenced
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.
1995
Leukemia and/or myeloproliferative syndrome in neonates with Down Syndrome
1997
Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
2013
PERIPHERAL VS. CENTRAL BLOOD CULTURES IN PATIENTS ADMITTED TO A PEDIATRIC ONCOLOGY WARD
1999
Adenoviral Infections in Pediatric Transplant Recipients
2006
The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children
2013
Myelodysplasia and acute megakaryoblastic leukemia in down's syndrome
1994
Improved survival in severe acquired aplastic anemia of childhood
2000
Controlled pilot study of rapid amphotericn B infusions
1997
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma
2000
Predictors of Viridans Streptococcal Shock Syndrome in Bacteremic Children With Cancer and Stem-Cell Transplant Recipients
2004
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
2011